Gut Bacteria and Brain of the Baby
Launched by RENNES UNIVERSITY HOSPITAL · Jun 11, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Gut Bacteria and Brain of the Baby," is studying how the gut bacteria of premature babies may affect their brain development. The researchers want to understand how these tiny bacteria, which live in the intestines, might influence health outcomes as the baby grows. The study will involve 100 babies who were born moderately premature, specifically between 30 and 32 weeks of pregnancy. These babies will be followed by pediatricians until they reach 2 years old, allowing the researchers to gather important information over time.
To be eligible for this study, babies must be born at the Rennes Hospital or transferred there within the first day of life. Parents must agree in writing to let their baby participate, and the mother should have a social security system for support. It's important to note that babies with certain health issues, like genetic diseases or major digestive defects, cannot take part in the study. If your baby qualifies, you can expect regular check-ups and support from the medical team as they monitor your child's growth and development. This trial aims to better understand the health of premature infants and could help improve care for them in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterms born at gestational age of 30-326/7 weeks of amenorrhea
- • Preterms born in Rennes hospital or preterms born in another hospital but moved to Rennes hospital during the first 24 h of postnatal life
- • Parents or holder of the parental authority who give in writing their free, prior and informed consent for recruitment of their baby who has a social security system
- • Mother of the baby who gives in writing her free, prior and informed consent to be involved in the present study
- • Mother of the baby who has a social security system
- Exclusion Criteria:
- • Preterms born with a genetic disease
- • Preterms born with a digestive defect
- • Uncompetent parents under the protection of guardianship or tutelage services
About Rennes University Hospital
Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials